BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21557271)

  • 1. Inhibition of acid ceramidase by a 2-substituted aminoethanol amide synergistically sensitizes prostate cancer cells to N-(4-hydroxyphenyl) retinamide.
    Gouazé-Andersson V; Flowers M; Karimi R; Fabriás G; Delgado A; Casas J; Cabot MC
    Prostate; 2011 Jul; 71(10):1064-73. PubMed ID: 21557271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.
    Batra S; Reynolds CP; Maurer BJ
    Cancer Res; 2004 Aug; 64(15):5415-24. PubMed ID: 15289350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C6-ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth.
    Flowers M; Fabriás G; Delgado A; Casas J; Abad JL; Cabot MC
    Breast Cancer Res Treat; 2012 Jun; 133(2):447-58. PubMed ID: 21935601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
    Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
    Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP
    J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular glutathione levels determine cell sensitivity to apoptosis induced by the antineoplasic agent N-(4-hydroxyphenyl) retinamide.
    Morales MC; Pérez-Yarza G; Nieto-Rementeria N; Boyano MD; Jangi M; Atencia R; Asumendi A
    Anticancer Res; 2005; 25(3B):1945-51. PubMed ID: 16158929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-mediated fenretinide (4-HPR) resistance in childhood acute lymphoblastic leukemia cells.
    Yang B; Fan L; Fang L; He Q
    Cancer Chemother Pharmacol; 2006 Oct; 58(4):540-6. PubMed ID: 16520989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAG-1 promotes apoptosis induced by N-(4-hydroxyphenyl)retinamide in human cervical carcinoma cells.
    Yang X; Hao Y; Ding Z; Pater A
    Exp Cell Res; 2000 May; 256(2):491-9. PubMed ID: 10772821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts.
    Samsel L; Zaidel G; Drumgoole HM; Jelovac D; Drachenberg C; Rhee JG; Brodie AM; Bielawska A; Smyth MJ
    Prostate; 2004 Mar; 58(4):382-93. PubMed ID: 14968439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibitory effects on hepatocarcinoma and B16 melanoma cells by N-(4-hydrophenyl) retinamide].
    Zhang L; Wu XZ
    Shi Yan Sheng Wu Xue Bao; 2003 Dec; 36(6):421-7. PubMed ID: 14724932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanisms of fenretinide-triggered apoptosis in leukemic cells].
    Xiao DK; Du YZ; Fan HY; Chen YL; Chen Z; Zhang J; Wang KK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):975-8. PubMed ID: 16403262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity and acid ceramidase inhibitory activity of 2-substituted aminoethanol amides.
    Bedia C; Canals D; Matabosch X; Harrak Y; Casas J; Llebaria A; Delgado A; Fabriás G
    Chem Phys Lipids; 2008 Nov; 156(1-2):33-40. PubMed ID: 18760267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer.
    Brewer M; Wharton JT; Wang J; McWatters A; Auersperg N; Gershenson D; Bast R; Zou C
    Gynecol Oncol; 2005 Aug; 98(2):182-92. PubMed ID: 15907982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenretinide: induction of apoptosis and endogenous transforming growth factor beta in PC-3 prostate cancer cells.
    Roberson KM; Penland SN; Padilla GM; Selvan RS; Kim CS; Fine RL; Robertson CN
    Cell Growth Differ; 1997 Jan; 8(1):101-11. PubMed ID: 8993839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bak: a downstream mediator of fenretinide-induced apoptosis of SH-SY5Y neuroblastoma cells.
    Lovat PE; Oliverio S; Corazzari M; Rodolfo C; Ranalli M; Goranov B; Melino G; Redfern CP; Piacentini M
    Cancer Res; 2003 Nov; 63(21):7310-3. PubMed ID: 14612528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis-related genes in human prostate carcinoma cells.
    Sun SY; Yue P; Lotan R
    Mol Pharmacol; 1999 Mar; 55(3):403-10. PubMed ID: 10051523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS-dependent mechanism involving ER stress and JNK activation.
    Appierto V; Tiberio P; Villani MG; Cavadini E; Formelli F
    Carcinogenesis; 2009 May; 30(5):824-31. PubMed ID: 19325135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-(4-hydroxyphenyl)retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase.
    Wang H; Maurer BJ; Reynolds CP; Cabot MC
    Cancer Res; 2001 Jul; 61(13):5102-5. PubMed ID: 11431347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of mitochondria-derived reactive oxygen species, cytochrome C and caspase-3 in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells.
    Suzuki S; Higuchi M; Proske RJ; Oridate N; Hong WK; Lotan R
    Oncogene; 1999 Nov; 18(46):6380-7. PubMed ID: 10597238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of ceramide generation and metabolism in response to fenretinide--Diversity within and among leukemia.
    Morad SA; Davis TS; Kester M; Loughran TP; Cabot MC
    Leuk Res; 2015 Oct; 39(10):1071-8. PubMed ID: 26220867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.